Inder Kaul

Inder Kaul, MD, MPH, currently serves as Chief Medical Officer at Draig Therapeutics since May 2025. Previously, Inder held senior leadership positions at Bristol Myers Squibb as Senior Vice President of Clinical Development in Neuropsychiatry, and Karuna Therapeutics as Senior Vice President of Clinical Development. Inder founded Kaul Consulting LLC, offering comprehensive development services from preclinical to regulatory affairs. Earlier career highlights include serving as President of Product Development and Chief Medical Officer at Asahi Kasei Pharma America Corporation, and Vice President roles at Oscient Pharmaceuticals and AAI Development Services. Inder's extensive background encompasses oversight of clinical operations, regulatory affairs, and strategic planning in various therapeutic areas. Inder earned a Doctor of Medicine in Anesthesiology from the University of Kashmir and a Master of Public Health in Epidemiology & Biostatistics from Harvard University.